261 related articles for article (PubMed ID: 15210525)
1. Postmenopausal estrogen use affects risk for Parkinson disease.
Currie LJ; Harrison MB; Trugman JM; Bennett JP; Wooten GF
Arch Neurol; 2004 Jun; 61(6):886-8. PubMed ID: 15210525
[TBL] [Abstract][Full Text] [Related]
2. Estrogen replacement therapy and risk of Alzheimer disease.
Paganini-Hill A; Henderson VW
Arch Intern Med; 1996 Oct; 156(19):2213-7. PubMed ID: 8885820
[TBL] [Abstract][Full Text] [Related]
3. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
[TBL] [Abstract][Full Text] [Related]
4. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.
Heckbert SR; Weiss NS; Koepsell TD; Lemaitre RN; Smith NL; Siscovick DS; Lin D; Psaty BM
Arch Intern Med; 1997 Jun; 157(12):1330-6. PubMed ID: 9201007
[TBL] [Abstract][Full Text] [Related]
5. A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease.
Zheng K; Heydari B; Simon DK
Arch Neurol; 2003 May; 60(5):722-5. PubMed ID: 12756136
[TBL] [Abstract][Full Text] [Related]
6. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.
Ramnath N; Menezes RJ; Loewen G; Dua P; Eid F; Alkhaddo J; Paganelli G; Natarajan N; Reid ME
Oncology; 2007; 73(5-6):305-10. PubMed ID: 18493157
[TBL] [Abstract][Full Text] [Related]
9. The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women.
Abramov Y; Borik S; Yahalom C; Fatum M; Avgil G; Brzezinski A; Banin E
Menopause; 2004; 11(1):62-8. PubMed ID: 14716184
[TBL] [Abstract][Full Text] [Related]
10. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
[TBL] [Abstract][Full Text] [Related]
12. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Rosendaal FR; Psaty BM
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2807-12. PubMed ID: 16973976
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
[TBL] [Abstract][Full Text] [Related]
14. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?
Wolf LA; Terry PD; Potter JD; Bostick RM
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):676-83. PubMed ID: 17416757
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
[TBL] [Abstract][Full Text] [Related]
17. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen therapy on hearing in postmenopausal women.
Kilicdag EB; Yavuz H; Bagis T; Tarim E; Erkan AN; Kazanci F
Am J Obstet Gynecol; 2004 Jan; 190(1):77-82. PubMed ID: 14749639
[TBL] [Abstract][Full Text] [Related]
19. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
